𝔖 Bobbio Scriptorium

✦ LIBER ✦

An Open Label, Non-randomized, Prospective Clinical Trial Evaluating the Immunogenicity of Branded Enoxaparin Versus Biosimilars in Healthy Volunteers

✍ Scribed by Gomes, M.; Ramacciotti, E.; Hoppensteadt, D.; Walenga, J. M.; Lewis, B.; Thethi, I.; Fareed, J.

Book ID: 121379079
Publisher: SAGE Publications
Year: 2011
Tongue: English
Weight: 276 KB
Volume: 17
Category: Article
ISSN: 1076-0296
DOI: 10.1177/1076029610393332

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

15 OPEN-LABEL PROSPECTIVE RANDOMIZED 48

15 OPEN-LABEL PROSPECTIVE RANDOMIZED 48 WEEK CLINICAL TRIAL: ROSIGLITAZONE VERSUS ROSIGLITAZONE AND METFORMIN (AVANDAMET) VERSUS ROSIGLITAZONE AND LOSARTAN IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

✍ D. Torres; F.J. Jones; J. Shaw; C. Williams; J.A. Ward; S.A. Harrison 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Clinical trial: evaluation of gastric ac

Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers

✍ P. Miner Jr; J. Plachetka; E. Orlemans; J. G. Fort; M. Sostek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB